1.58
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Open
Low
1.35
High
7.70
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.58 | 12:19:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.57 | 1.56 | 1.595 | 1.58 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.57 | 1.58 | 0.01 | 1 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 672 | 445,637 | $ 1.5754 | $ 702,055 | - | 1.35 - 7.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:19:57 | 100 | $ 1.58 | USD |
Period:
Draw Mode:
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 986.12M | 624.13M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 35.77M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.74 | 1.80 | 1.53 | 1.62 | 1,136,032 | -0.16 | -9.2% |
| 1 Month | 1.70 | 1.95 | 1.35 | 1.60 | 2,175,721 | -0.12 | -7.06% |
| 3 Months | 2.72 | 2.99 | 1.35 | 1.92 | 2,577,324 | -1.14 | -41.91% |
| 6 Months | 5.80 | 7.70 | 1.35 | 3.18 | 3,583,109 | -4.22 | -72.76% |
| 1 Year | 5.32 | 7.70 | 1.35 | 3.62 | 4,008,578 | -3.74 | -70.3% |
| 3 Years | 0.556 | 10.01 | 0.0552 | 3.23 | 2,898,087 | 1.02 | 184.17% |
| 5 Years | 1.05 | 10.01 | 0.0552 | 3.09 | 1,848,193 | 0.53 | 50.48% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
